Spero Therapeutics
SPRO
#10353
Rank
โ‚น4.00 B
Marketcap
โ‚น68.76
Share price
-10.20%
Change (1 day)
-67.43%
Change (1 year)

EPS for Spero Therapeutics (SPRO)

EPS in 2026 (TTM): โ‚น11.38

According to Spero Therapeutics's latest financial reports the company's current EPS (TTM) is โ‚น12.97. In 2025 the company made an earnings per share (EPS) of โ‚น13.90 an increase over its 2024 EPS that were of -โ‚น117.69.

EPS history for Spero Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น11.38-18.12%
2025โ‚น13.90-111.81%
2024-โ‚น117.69
2022-โ‚น153.83
2020-โ‚น334.549.39%
2019-โ‚น305.8125.48%
2018-โ‚น243.72-51.35%
2017-โ‚น500.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
IBM
IBM
โ‚น1,103 8,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thomson Reuters
TRI
โ‚น333.40 2,469.83%๐Ÿ‡จ๐Ÿ‡ฆ Canada
Franklin Covey
FC
โ‚น42.63 228.57%๐Ÿ‡บ๐Ÿ‡ธ USA